Fresenius SE

All - 2009

09.12.2009Fresenius Medical Care announces Management Board Changes
PDF Text as PDF-file
03.11.2009Fresenius SE: Q1−3/2009: Strong organic growth achieved − Outlook for 2009 fully confirmed (for additional tables see PDF-file)
PDF Text as PDF-file
03.11.2009Fresenius Medical Care Reports Strong Third Quarter and Nine Months Results; Improved Guidance for 2009 (for additional tables see PDF-file)
PDF Text as PDF-file
29.10.2009Fresenius Medical Care announces presentation of first results from the CALMAG study for phosphate binder OsvaRen®
PDF Text as PDF-file
13.10.2009Fresenius Medical Care introduces programme for improved PD therapy
PDF Text as PDF-file
04.08.2009Fresenius SE: H1 2009 - Maintains growth momentum; Confirms outlook (for additional tables see PDF-file)
PDF Text as PDF-file
04.08.2009Fresenius Medical Care Reports Strong Second Quarter and Half Year Results and Confirms Outlook for 2009 (for additional tables see PDF-file)
PDF Text as PDF-file
03.06.2009Fresenius successfully raises € 138 million via a tap to its 2006 Senior Notes
PDF Text as PDF-file
03.06.2009Fresenius announces Senior Notes Offering
PDF Text as PDF-file
22.05.2009New Renal Pharma Website from Fresenius Medical Care – Interactive Online Training in Bone Metabolism
PDF Text as PDF-file
06.05.2009Fresenius Medical Care announces completion of government investigation
PDF Text as PDF-file
05.05.2009Fresenius Medical Care opens its first dialysis clinic in Sweden
PDF Text as PDF-file
30.04.2009Fresenius SE: Q1 2009 - Successful start into 2009 (for additional tables see PDF-file)
PDF Text as PDF-file
30.04.2009Fresenius Medical Care Reports Strong Start for 2009 and Confirms Outlook for Full Year (for additional tables see PDF-file)
PDF Text as PDF-file
23.04.2009Fresenius Biotech receives approval for Removab® by European Commission - First Drug worldwide for Treatment of Malignant Ascites
PDF Text as PDF-file
10.03.2009Fresenius Medical Care announces Resignation of Lawrence A. Rosen, Chief Financial Officer
PDF Text as PDF-file
05.03.2009Fresenius SE joins the DAX 30
PDF Text as PDF-file
19.02.2009Fresenius Medical Care Reports Strong Fourth Quarter and Full Year 2008 Results; Projects continued growth in 2009 (for additional tables see PDF-file)
PDF Text as PDF-file
19.02.2009Fresenius SE: Successful 2008 − Financial targets fully met or exceeded − Positive outlook for 2009 (for additional tables see PDF-file)
PDF Text as PDF-file
18.02.2009EMEA-Committee for Medicinal Products for Human Use issues positive opinion for Removab® (catumaxomab) for the treatment of malignant ascites
PDF Text as PDF-file
15.01.2009Fresenius successfully raises US$ 800 million equivalent with Offering of Senior Notes
PDF Text as PDF-file
12.01.2009Fresenius announces Senior Notes Offering
PDF Text as PDF-file
Home  >  Press  >  Press Releases  >  All  >  2009